Otros idiomas Huaren Pharmaceutical Co., Ltd.

Acciones

300110

CNE100000SW1

Precio de cierre Shenzhen S.E. Otros sitios de cotización 00:00:00 20/05/2024			Varia. Cinco días.	Varia. 1 de enero.
3,6 ^CNY	-0,28 %		-3,23 %	-14,69 %

24/04	Huaren Pharmaceutical Co. presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
24/04	Huaren Pharmaceutical Co. Huaren Pharmaceutical Co., Ltd. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Huaren Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023	25/04
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	24/04
Huaren Pharmaceutical Co., Ltd. cancelled the transaction announced on March 23, 2023	23/04
Huaren Pharma's Unit Gets Nod for Medical Device	04/04
Huaren Pharma's Unit Gets Nod to Add Specifications to Antibiotic Product	22/02
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24/10/23
Huaren Pharmaceutical Co., Ltd.(XSEC:300110) added to S&P Global BMI Index	18/09/23
Huaren Pharmaceutical Co., Ltd. Announces Director Appointments	13/09/23
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	25/08/23
Huaren Pharmaceutical Co., Ltd. Approves Final Cash Dividend for the Year 2022, Payable on 12 July 2023	03/07/23
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	19/04/23
Huaren Pharmaceutical Co., Ltd. Proposes Final Dividend for 2022	27/03/23
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	24/03/23
Huaren Pharmaceutical Co., Ltd. announced that it expects to receive CNY 1.339851 billion in funding from Xi'an Qujiang Tianshou Great Health Investment Partnership Enterprise ( Limited Partnership)	23/03/23
Huaren Pharma Appoints Executive President	30/12/22
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	20/10/22
Huaren Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	19/08/22
Huaren Pharmaceutical Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on June 17, 2022	13/06/22
Huaren Pharmaceutical Co., Ltd. Approves Board Appointments	22/04/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Huaren Pharmaceutical Co., Ltd.

Acciones

300110

CNE100000SW1

Otros idiomas

Filtros